Alveolar Ridge Augmentation Using Minimally Invasive Subperiosteal Tunneling With Xenogenic Bone Graft and PRF

NCT07079917 | Not Yet Recruiting

• 1 other identifier: will be ready at end of study
• Study Type: interventional
• Target: 16
• Locations: 1 country
• Sites: 1

Brief Summary

surgical horizontal augmentation for maxillary alveolar ridge using minimally invasive subperiosteal tunneling in comparison to conventional surgical technique

Conditions

Alveolar Bone Loss

Outcome Measures

Primary Outcomes (1)

• Maxillary alveolar bone width

  increase of the alveolar bone buccolingually for horizontal ridge augmentation

  6 months

Study Arms (2)

subperiosteal tunneling for horizontal alveolar ridge augmentation

ACTIVE COMPARATOR

subperiosteal dissection through horizontal incision

Procedure: subperiosteal tunneling for horizontal alveolar ridge augmentation

conventional surgical approach for horizontal alveolar ridge augmentation

ACTIVE COMPARATOR

conventional full thickness trapezoidal flap for alveolar ridge augmentation

Procedure: conventional alveolar ridge augmentation

Interventions

subperiosteal tunneling for horizontal alveolar ridge augmentation PROCEDURE

subperiosteal dissection through horizontal incision only

subperiosteal tunneling for horizontal alveolar ridge augmentation

conventional alveolar ridge augmentation PROCEDURE

horizontal alveolar ridge augmentation through trapezoidal flap

conventional surgical approach for horizontal alveolar ridge augmentation

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Adults over 18 years old seeking an implant-supported restoration with deficient horizontal posterior maxillary alveolar ridge, at area of one or two missed teeth of less than 5 mm buccolingual width.
• Minimum vertical height of 8 mm.
• Gingival tissue of healthy adequate keratinization, more than 2mm.

You may not qualify if:

• The presence of uncontrolled diabetes or any other systemic condition which may complicate the surgical procedure or interfere with bone healing
• Radiotherapy to the head and neck region
• Chemotherapy within the last 12 months
• Uncontrolled periodontitis
• Smoking
• Bisphosphonate therapy
• Pregnancy
• Presence of periapical infection or lesion

Sponsors & Collaborators

• Fayoum University: lead

Study Sites (1)

Fayoum University

Al Fayyum, Egypt

Location

MeSH Terms

Conditions

Alveolar Bone Loss

Condition Hierarchy (Ancestors)

Bone Resorption; Bone Diseases; Musculoskeletal Diseases; Periodontal Atrophy; Periodontal Diseases; Mouth Diseases; Stomatognathic Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Demonstrator at oral & maxillofacial department

Study Record Dates

• First Submitted: July 2, 2025
• First Posted: July 23, 2025
• Study Start: August 1, 2025
• Primary Completion: August 21, 2025
• Study Completion (Estimated): June 21, 2026
• Last Updated: July 23, 2025

Record last verified: 2025-07

Locations

EG (1)